CG Oncology, Inc. (CGON)
62.22
+0.29
(+0.47%)
USD |
NASDAQ |
Oct 21, 16:00
62.22
0.00 (0.00%)
After-Hours: 16:38
CG Oncology Market Cap : 5.494B for Oct. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 5.469B |
| October 19, 2026 | 5.295B |
| October 16, 2026 | 5.285B |
| October 15, 2026 | 5.463B |
| October 14, 2026 | 5.461B |
| October 13, 2026 | 5.510B |
| October 12, 2026 | 5.575B |
| October 09, 2026 | 5.636B |
| October 08, 2026 | 5.586B |
| October 07, 2026 | 5.509B |
| October 06, 2026 | 5.620B |
| October 05, 2026 | 6.068B |
| October 02, 2026 | 5.950B |
| October 01, 2026 | 6.036B |
| September 30, 2026 | 6.260B |
| September 29, 2026 | 6.227B |
| September 28, 2026 | 6.147B |
| September 25, 2026 | 5.930B |
| September 24, 2026 | 6.072B |
| September 23, 2026 | 6.478B |
| September 22, 2026 | 6.865B |
| September 21, 2026 | 6.910B |
| September 18, 2026 | 6.589B |
| September 17, 2026 | 6.678B |
| September 16, 2026 | 6.545B |
| Date | Value |
|---|---|
| September 15, 2026 | 6.407B |
| September 14, 2026 | 6.516B |
| September 11, 2026 | 6.389B |
| September 10, 2026 | 6.358B |
| September 09, 2026 | 6.355B |
| September 08, 2026 | 6.482B |
| September 04, 2026 | 6.594B |
| September 03, 2026 | 6.564B |
| September 02, 2026 | 6.587B |
| September 01, 2026 | 6.699B |
| August 31, 2026 | 6.637B |
| August 28, 2026 | 6.565B |
| August 27, 2026 | 6.977B |
| August 26, 2026 | 6.925B |
| August 25, 2026 | 6.972B |
| August 24, 2026 | 6.908B |
| August 21, 2026 | 7.048B |
| August 20, 2026 | 6.853B |
| August 19, 2026 | 7.125B |
| August 18, 2026 | 6.737B |
| August 17, 2026 | 6.809B |
| August 14, 2026 | 6.626B |
| August 13, 2026 | 6.597B |
| August 12, 2026 | 6.799B |
| August 11, 2026 | 6.802B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.303B |
| Oncolytics Biotech, Inc. | 64.09M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.961B |
| Anixa Biosciences, Inc. | 93.90M |
Market Cap Related Metrics
| PS Ratio | 823.07 |
| PEG Ratio | -0.4041 |
| Price to Book Value | 5.339 |
| Price | 62.22 |
| Earnings Yield | -4.33% |
| PEGY Ratio | -0.4041 |